CRDL Stock Analysis: Buy, Sell, or Hold?
CRDL - Cardiol Therapeutics Inc. Class A Common Shares
$0.95
0.00 (-0.34%)
▼
5d:
-5.25%
30d:
-0.66%
90d:
-13.86%
HOLD
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Apr 01, 2026
Get Alerted When CRDL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called CRDL this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: CRDL shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: CRDL shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: CRDL is currently trading at $0.95, which is considered oversold relative to its 30-day fair value range of $0.96 to $1.02.
Technical Outlook: Technically, CRDL is in a downtrend. The price is currently testing key support at $0.93. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: CRDL has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $7.90 (+731.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CRDL is in a downtrend. The price is currently testing key support at $0.93. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: CRDL has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $7.90 (+731.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$0.96 -
$1.02
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 731.4% below Wall St target ($7.90)
- CAUTION: 5-day price weakness (-5.2%) - monitor closely
Fair Price Analysis
30-Day Fair Range
$0.96 -
$1.02
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$0.93
Resistance Level
$1.07
Current Trend
Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-2.62
Wall Street Target
$7.90
(+731.4%)
Last updated: February 02, 2026 10:38 AM ET
Data refreshes hourly during market hours. Next update: 11:38 AM
Data refreshes hourly during market hours. Next update: 11:38 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CRDL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$180 | 62 BUY |
|
ZTS
Zoetis Inc |
STRONG BUY
19 analysts |
$154 | 56 HOLD |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$83 | 57 HOLD |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$22 | 55 HOLD |
|
HCM
HUTCHMED DRC |
STRONG BUY
14 analysts |
$21 | 57 HOLD |
